Tularik's P2P Acquisition

Tularik raised a round of funding on March 29, 2004. Investors include Amgen.

Tularik is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform …

Articles about Tularik's P2P Acquisition: